Cytos links with Singapore agency to develop flu vaccine
This article was originally published in Scrip
Executive Summary
Cytos Biotechnology and Singapore's Agency for Science, Technology and Research (A*STAR) have entered into a collaboration to develop a virus-like particle (VLP) prophylactic vaccine for influenza.